These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38933825)

  • 1. The positive association between hyperuricemia and polycystic ovary syndrome and analysis of related factors.
    Gong Z; Sun Y; Zhang L; Zhu X; Shi Y
    Front Endocrinol (Lausanne); 2024; 15():1356859. PubMed ID: 38933825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the prevalence of hyperuricemia and reproductive hormones in polycystic ovary syndrome.
    Mu L; Pan J; Yang L; Chen Q; Chen Y; Teng Y; Wang P; Tang R; Huang X; Chen X; Yang H
    Reprod Biol Endocrinol; 2018 Oct; 16(1):104. PubMed ID: 30359269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation Between Serum Uric Acid and Body Fat Distribution in Patients With Polycystic Ovary Syndrome.
    Zhang Y; Cai M; Dilimulati D; Lin Z; Sun H; Cui R; Fei H; Gao X; Zeng Q; Shao X; Zhang M; Qu S
    Front Endocrinol (Lausanne); 2021; 12():782808. PubMed ID: 35145476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum uric acid/creatinine ratio and free androgen index are synergistically associated with increased risk of polycystic ovary syndrome in obese women.
    El-Eshmawy MM; Ibrahim A; Bahriz R; Shams-Eldin N; Mahsoub N
    BMC Endocr Disord; 2022 Dec; 22(1):315. PubMed ID: 36514085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The application value of serum 25(OH)D3, uric acid, triglyceride, and homeostasis model assessment of insulin resistance in male patients with hyperuricemia combined with hypogonadism.
    Zhang Q; Chen W; Yun C; Wang J
    BMC Endocr Disord; 2021 May; 21(1):102. PubMed ID: 34022879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An inverse association between serum soluble receptor of advanced glycation end products and hyperandrogenism and potential implication in polycystic ovary syndrome patients.
    Liao Y; Huang R; Sun Y; Yue J; Zheng J; Wang L; Tao T; Ma J; Li S; Liu W
    Reprod Biol Endocrinol; 2017 Jan; 15(1):9. PubMed ID: 28125989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic disparities between obese and non-obese patients with polycystic ovary syndrome: implications for endometrial receptivity indicators.
    Li XL; Ji YF; Feng Y; Liu SW
    Gynecol Endocrinol; 2024 Dec; 40(1):2312895. PubMed ID: 38444321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dehydroepiandrosterone sulfate/free androgen index ratio predicts a favorable metabolic profile in patients with polycystic ovary syndrome.
    Nadir A; Temizkan S; Ozderya A; Temizkan O; Orbay E; Aydin K
    Gynecol Endocrinol; 2019 Feb; 35(2):128-132. PubMed ID: 30324855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled attenuation parameters to assess liver steatosis in obese patients with polycystic ovary syndrome.
    Wang D; Nan N; Bing H; He B
    Front Endocrinol (Lausanne); 2023; 14():1241734. PubMed ID: 37720537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin Is Associated With Insulin Resistance and Beta-Cell Dysfunction in Infertile Women With Polycystic Ovary Syndrome.
    Yang H; Lin J; Li H; Liu Z; Chen X; Chen Q
    Front Endocrinol (Lausanne); 2021; 12():571229. PubMed ID: 33716958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of MEP1A gene variants with insulin metabolism in central European women with polycystic ovary syndrome.
    Lam UD; Lerchbaum E; Schweighofer N; Trummer O; Eberhard K; Genser B; Pieber TR; Obermayer-Pietsch B
    Gene; 2014 Mar; 537(2):245-52. PubMed ID: 24388959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
    Singh S; Akhtar N; Ahmad J
    Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum fibrinogen-like protein 1 as a novel biomarker in polycystic ovary syndrome: a case-control study.
    Zhang Y; Dilimulati D; Chen D; Cai M; You H; Sun H; Gao X; Shao X; Zhang M; Qu S
    J Endocrinol Invest; 2022 Nov; 45(11):2123-2130. PubMed ID: 35790683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in nonesterified free fatty acid trafficking rather than hyperandrogenism contribute to metabolic health in obese women with polycystic ovary syndrome.
    Ezeh U; Chen YI; Pall M; Buyalos RP; Chan JL; Pisarska MD; Azziz R
    Fertil Steril; 2024 Jun; 121(6):1040-1052. PubMed ID: 38307453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between blood uric acid levels and body composition in patients with polycystic ovary syndrome].
    Li X; Zhang JF; Feng YR; Tang QT; Kuai D; Tian WY; Zhang HY
    Zhonghua Fu Chan Ke Za Zhi; 2023 Jul; 58(7):508-515. PubMed ID: 37474324
    [No Abstract]   [Full Text] [Related]  

  • 17. Eight-hour time-restricted feeding improves endocrine and metabolic profiles in women with anovulatory polycystic ovary syndrome.
    Li C; Xing C; Zhang J; Zhao H; Shi W; He B
    J Transl Med; 2021 Apr; 19(1):148. PubMed ID: 33849562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyslipidaemia in polycystic ovarian syndrome: different groups, different aetiologies?
    Meirow D; Raz I; Yossepowitch O; Brzezinski A; Rosler A; Schenker JG; Berry EM
    Hum Reprod; 1996 Sep; 11(9):1848-53. PubMed ID: 8921052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dyslipidemia in relation to body mass index and insulin resistance in Chinese women with polycystic ovary syndrome.
    Hong Y; Yang D; Liu W; Zhao X; Chen X; Li L
    J Biol Regul Homeost Agents; 2011; 25(3):365-74. PubMed ID: 22023761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women?
    Yang S; Wang Q; Huang W; Song Y; Feng G; Zhou L; Tan J
    Gynecol Endocrinol; 2016; 32(1):38-41. PubMed ID: 26291816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.